Course: Frequency and Outcomes of Ipsilateral Axillary Lymphadenopathy After COVID-19 Vaccination
CME Credits: 1.00
Released: 2022-06-08
Ipsilateral axillary lymphadenopathy (IAL) after COVID-19 vaccination results in diagnostic conundrums.- Expert guidelines advise IAL management based on patient symptoms, imaging results, and risk factors.,, We report on the frequency and outcomes of breast imaging–identified IAL after recent COVID-19 vaccination.
Educational Objective
To identify the key insights or developments described in this article
View Full Course